Vaccines against Covid-19: the Comparative Estimates of Risks in Adenovirus Vectors

Relevance. The vaccine against the SARS-Cov-2 coronavirus is considered as the most promising approach to curb (tame) a current pandemic and prevent new one. Three vaccines (AstraZeneca’s СhAdOx1 nCov-19, CanSino’s vaccine and Russia’s Sputnik V one) are in Phase III clinical trials and have the S p...

Full description

Saved in:
Bibliographic Details
Main Author: E. P. Kharchenko
Format: Article
Language:Russian
Published: Numikom LLC 2020-11-01
Series:Эпидемиология и вакцинопрофилактика
Subjects:
Online Access:https://www.epidemvac.ru/jour/article/view/1080
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850025563332280320
author E. P. Kharchenko
author_facet E. P. Kharchenko
author_sort E. P. Kharchenko
collection DOAJ
description Relevance. The vaccine against the SARS-Cov-2 coronavirus is considered as the most promising approach to curb (tame) a current pandemic and prevent new one. Three vaccines (AstraZeneca’s СhAdOx1 nCov-19, CanSino’s vaccine and Russia’s Sputnik V one) are in Phase III clinical trials and have the S protein as immunogen but different adenovirus vectors. It is known adverse neurological events associated with the СhAdOx1 nCov-19 vacсine.Aim is to investigate the distribution of homologous sequences of adenovirus proteins in human nervous and immune systems proteins, estimate potential risks of using adenovirus vectors in vaccines and discuss possible mechanisms inducing immune damage in the nervous system.Materials and methods. For the computer analysis of peptide (immune epitope) relationship between adenovirus structural proteins and human proteins, the search of homologous sequences was made. All protein sequences were used from databases available on the INTERNET.Results. Among adenoviruses (НАд5, НАд26 , ChАдY25, and SAd3) ChАдY25 has the highest content of sequences homologous to human nervous system proteins that may be the cause of autoimmune complications in vaccination.Conclusion: In AstraZeneca’s СhAdOx1 nCov-19 vaccine there are a large number of peptide sequences homologous to human nervous system proteins and it allows to predict the possible risks with this vaccine.
format Article
id doaj-art-2daedff9ec3549bc9ddc3e148ee1d841
institution DOAJ
issn 2073-3046
2619-0494
language Russian
publishDate 2020-11-01
publisher Numikom LLC
record_format Article
series Эпидемиология и вакцинопрофилактика
spelling doaj-art-2daedff9ec3549bc9ddc3e148ee1d8412025-08-20T03:00:49ZrusNumikom LLCЭпидемиология и вакцинопрофилактика2073-30462619-04942020-11-0119541710.31631/2073-3046-2020-19-5-4-17674Vaccines against Covid-19: the Comparative Estimates of Risks in Adenovirus VectorsE. P. Kharchenko0Sechenov Institute of Evolutionary Physiology and BiochemistryRelevance. The vaccine against the SARS-Cov-2 coronavirus is considered as the most promising approach to curb (tame) a current pandemic and prevent new one. Three vaccines (AstraZeneca’s СhAdOx1 nCov-19, CanSino’s vaccine and Russia’s Sputnik V one) are in Phase III clinical trials and have the S protein as immunogen but different adenovirus vectors. It is known adverse neurological events associated with the СhAdOx1 nCov-19 vacсine.Aim is to investigate the distribution of homologous sequences of adenovirus proteins in human nervous and immune systems proteins, estimate potential risks of using adenovirus vectors in vaccines and discuss possible mechanisms inducing immune damage in the nervous system.Materials and methods. For the computer analysis of peptide (immune epitope) relationship between adenovirus structural proteins and human proteins, the search of homologous sequences was made. All protein sequences were used from databases available on the INTERNET.Results. Among adenoviruses (НАд5, НАд26 , ChАдY25, and SAd3) ChАдY25 has the highest content of sequences homologous to human nervous system proteins that may be the cause of autoimmune complications in vaccination.Conclusion: In AstraZeneca’s СhAdOx1 nCov-19 vaccine there are a large number of peptide sequences homologous to human nervous system proteins and it allows to predict the possible risks with this vaccine.https://www.epidemvac.ru/jour/article/view/1080vaccinescovid-19adenovirusesvectorcomplicationnervous system
spellingShingle E. P. Kharchenko
Vaccines against Covid-19: the Comparative Estimates of Risks in Adenovirus Vectors
Эпидемиология и вакцинопрофилактика
vaccines
covid-19
adenoviruses
vector
complication
nervous system
title Vaccines against Covid-19: the Comparative Estimates of Risks in Adenovirus Vectors
title_full Vaccines against Covid-19: the Comparative Estimates of Risks in Adenovirus Vectors
title_fullStr Vaccines against Covid-19: the Comparative Estimates of Risks in Adenovirus Vectors
title_full_unstemmed Vaccines against Covid-19: the Comparative Estimates of Risks in Adenovirus Vectors
title_short Vaccines against Covid-19: the Comparative Estimates of Risks in Adenovirus Vectors
title_sort vaccines against covid 19 the comparative estimates of risks in adenovirus vectors
topic vaccines
covid-19
adenoviruses
vector
complication
nervous system
url https://www.epidemvac.ru/jour/article/view/1080
work_keys_str_mv AT epkharchenko vaccinesagainstcovid19thecomparativeestimatesofrisksinadenovirusvectors